<DOC>
	<DOC>NCT01643629</DOC>
	<brief_summary>This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Androgenetic Alopecia. The study is being conducted at 2 centers in India. The primary endpoints are Improvement in Caliber &amp; Density of hair and Improvement in Photographic assessment from randomization to end of study. The secondary endpoints are Physicians and Patients self assessment score.</brief_summary>
	<brief_title>A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<mesh_term>Minoxidil</mesh_term>
	<criteria>Male subjects, aged between 18 to 50 years (both inclusive) and in general good health Subjects willing to refrain from other AGA treatments during the entire study duration Subjects who are willing to give informed consent and adhere to the study protocol. Subjects aged &lt;18 or &gt; 50 years Subjects with dermatological disorder of scalp that might interfere with study evaluation Subjects on Anticoagulant therapy Subjects with clinically significant medical or psychiatric disease as determined by the investigator. Subjects with dermatological disorder of scalp that might interfere with study evaluation Subjects unwilling to or unable to comply with the study protocol.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>